Nutex Health Inc. is classed by the SEC under Services-Business Services, NEC (industry code 7389), based in Houston, TX. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $875 million and a profit of $71 million (its filed statements).
Marketplace businessServices-Business Services, NECHouston, TXfilings since 20098 of 9 filed, 1 estimated
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a marketplace business: prior from its industry code (SEC 7389, Services-Business Services, NEC); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 5.2 out of ten, 8 of 9 metrics filed and 1 estimated: past 3.1 out of ten, present 6.1 out of ten, future 5.6 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
Surviving crises (past): 0.1 out of ten. 34 warning events since 2017; the latest 2026-08-31. 0th percentile among 105 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Track record (past): 5.5 out of ten. +273.4% a year over 9 filed years; profitable in 5 of 9. 55th percentile among 99 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Shareholder treatment (past): 1.9 out of ten. Share count grew 16.9% a year. 2% of cash flow returned. Insiders: 1 sales, 5 purchases. 19th percentile among 70 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Financial health (present): 5.9 out of ten. ROE 17%: 17¢ of profit per shareholder dollar. Leverage 54%: owes 54¢ per asset dollar. 59th percentile among 98 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Industry position (present): 7.0 out of ten. top 30% of 101 in its family; net margin 8.1%. 70th percentile among 101 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Leadership (present): 4.7 out of ten. CrossAssetData estimate 4.7/10, confidence 35 of 100 (one part). 47th percentile among 76 sector filers. A CrossAssetData estimate, not a filed reading: one part, confidence 35 of 100; a filing that carries the missing parts replaces this estimate with the filed reading.
Room to expand (future): 7.1 out of ten. top 29% of 99 in its family for room to expand. 71st percentile among 99 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Growth drivers (future): 3.0 out of ten. bottom 30% of 99 in its family for growth drivers. 30th percentile among 99 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Expectations vs reality (future): 8.7 out of ten. top 13% of 93 in its family for expectations against reality. 87th percentile among 93 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
The filing record
Newest annual report: Form 10-K filed 2026-03-05 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-06 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-08-06 (on EDGAR). Newest filing: Form 8-A12B, 2026-09-22. Filings on record since 2009. Read from EDGAR 2026-10-12.
Where the revenue comes from
Product and service lines in fiscal 2025: Hospital Division 96%, Population Health Management Division 4%. As tagged in its annual report (Form 10-K, filed 2026-03-05).
Who runs it
Vo, Thomas T. (Chief Executive Officer); Hosseinion, Warren (President); Bates, Jon Christian (Chief Financial Officer); Bamburg, Wesley Shane (Chief Operating Officer); Montgomery, Pamela W. (Chief Legal Officer-Healthcare); Chang, Michael L. (Chief Medical Officer); Luqman, Elisa V (Chief Legal Officer - SEC); Saunders, Scott J (director); Grenas, Cheryl Yvonne (director); Jaumot, Frank E (director); and 2 more. 12 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.